GSK and Earvin “Magic” Johnson to Host Community Awareness Events about Older Adult Risk for RSV at YMCA Locations
05 Setembro 2023 - 9:00AM
Business Wire
- Four events will convene public health leaders and older adults
in major cities across the US as they take part in community
conversations about Respiratory Syncytial Virus (RSV)
- Earvin “Magic” Johnson will be joined by healthcare
professionals and patient advocates to educate and raise awareness
on the risk of RSV infection for people 60 years of age and
older
GSK plc (LSE/NYSE: GSK) and YMCA of the USA will host GSK’s
Sideline RSV “Community Conversations” event series as part of
their campaign efforts to raise awareness about RSV infection in
older adults. The events will take place at four YMCA locations
across the country (Chicago, Los Angeles, New York City and
Phoenix), joined by GSK’s campaign spokesperson Earvin “Magic”
Johnson, to help spark important conversations about RSV, a common,
contagious respiratory virus.1,2 Kicking off in September and
running through RSV Awareness Month in October, the private events
will include perspectives from medical professionals, and patients
and convene public health leaders, media, and 60+ YMCA members.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230901805289/en/
(Photo: Business Wire)
“As a dedicated public health advocate, I’m excited to be able
to visit older adults in their communities to talk about their risk
for RSV infection,” said Johnson. “Like many of us, and being over
60 myself, I used to be unaware of the effect that RSV can have on
older adults. Now, I’m passionate about educating others and
encouraging them to understand their risks and be proactive about
their health.”
Adults at highest risk for severe RSV infection include older
adults, and adults with certain underlying medical conditions, such
as chronic obstructive pulmonary disease (COPD), asthma or chronic
heart failure (CHF).1 Each year approximately 177,000 adults 65 and
older are hospitalized in the US due to RSV and an estimated 14,000
of those cases result in death.3 For adults 60 and older, some data
suggest that there is an increased risk for severe RSV infection
that can lead to hospitalization.4,5
“We are beyond excited to host these events with GSK and Magic
Johnson as the efforts align with the spirit and ultimate goal of
the Y, which is to strengthen the foundations of community through
improved individual and community wellbeing,” said Heather Hodge,
Y-USA’s Senior Director of Equity, Access, Engagement and Health
Approaches. “Our hope is these events will help ensure older adults
and their loved ones understand the reality of RSV infection and
have the information they need so that they can take action to
protect themselves.”
To learn more, visit www.SidelineRSV.com. If you’re 60 years of
age or older, speak with your healthcare provider or pharmacist
about RSV and vaccination.
About Sideline RSV Sideline RSV is a health education
campaign aimed to help older adults and their loved ones understand
the risks of RSV. The campaign will help bring the RSV conversation
among older adults center court to educate around the risk for
severe complications from RSV and encourage conversations with
their doctor or other healthcare professionals. Visit
www.SidelineRSV.com and follow the Sideline RSV campaign on
Facebook and Instagram.
About respiratory syncytial virus (RSV) in older adults
RSV is a common contagious virus that can affect the lungs and
breathing passages.6 Typical symptoms of RSV include fever, cough,
sore throat, runny nose, congestion, headache and tiredness.7 RSV
can spread easily when someone who is infected coughs or sneezes
and is likely to be transmitted by touching a contaminated surface
before touching the eyes, nose or mouth.2 Each year approximately
177,000 adults 65 years and older are hospitalized in the US due to
RSV and an estimated 14,000 of those cases result in death.3 For
adults 60 and older, some data suggest that there is an increased
risk for severe RSV infection that can lead to hospitalization.4,5
RSV can exacerbate certain underlying medical conditions, such as
chronic obstructive pulmonary disease (COPD), asthma and chronic
heart failure, and can lead to severe outcomes, such as pneumonia,
hospitalization, and death.1
About GSK GSK is a global biopharma company with a
purpose to unite science, technology, and talent to get ahead of
disease together. Find out more at gsk.com/company.
About the Y Driven by its founding mission, the Y has
served as a leading nonprofit committed to strengthening community
for more than 177 years. The Y empowers everyone, no matter who
they are or where they are from, by ensuring access to resources,
relationships and opportunities for all to learn, grow and thrive.
By bringing together people from different backgrounds,
perspectives and generations, the Y’s goal is to improve overall
health and well-being, ignite youth empowerment and demonstrate the
importance of connections in and across 10,000 communities
nationwide. ymca.org
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or
projections made by GSK, including those made in this announcement,
are subject to risks and uncertainties that may cause actual
results to differ materially from those projected. Such factors
include, but are not limited to, those described under Item 3.D
'Risk factors” in the company's Annual Report on Form 20-F for
2022, and Q1 Results for 2023 and any impacts of the COVID-19
pandemic.
Registered in England & Wales: No. 3888792
Registered Office: 980 Great West Road Brentford,
Middlesex TW8 9GS
References
- Centers for Disease Control and Prevention (CDC). RSV in Older
Adults and Adults with Chronic Medical Conditions. Available at:
https://www.cdc.gov/rsv/high-risk/older-adults.html. Accessed
August 2023.
- Centers for Disease Control and Prevention. RSV Transmission.
Available at: https://www.cdc.gov/rsv/about/transmission.html.
Accessed August 2023.
- Falsey AR, et al. N Engl J Med 2005; 352:1749-1759 DOI:
10.1056/NEJMoa043951. Accessed August 2023.
- Tseng HF, et al. Severe morbidity and short- and mid- to
long-term mortality in older adults hospitalized with respiratory
syncytial virus infection. J Infect Dis. 2020;222(8):1298-1310.
doi:10.1093/infdis/jiaa361.
- Belongia EA, et al. Clinical features, severity, and incidence
of RSV illness during 12 consecutive seasons in a community cohort
of adults ≥60 years old. Open Forum Infect Dis. 2018;5(12):ofy316.
doi:10.1093/ofid/ofy316.
- Centers for Disease Control and Prevention (CDC). RSV
(Respiratory Syncytial Virus). Available at:
https://www.cdc.gov/rsv/index.html. Accessed August 2023.
- Centers for Disease Control and Prevention. Symptoms and Care.
Available at: https://www.cdc.gov/rsv/about/symptoms.html. Accessed
August 2023.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230901805289/en/
GSK inquiries Media: Kathleen Quinn +1 202 603 5003
(Washington DC)
Alison Hunt +1 540 742 3391 (Washington DC)
Investor Relations: Jeff McLaughlin +1 215 751 7002
(Philadelphia)
Frannie DeFranco +1 215 751 4855 (Philadelphia)
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024